Search
Naminidil
go.drugbank.com/drugs/DB20227ExperimentalThe usage of the INN stem '-dil' in the name indicates that Naminidil is a vasodilator. Naminidil has a monoisotopic molecular weight of 269.16 Da.
Atelocantel
go.drugbank.com/drugs/DB20525ExperimentalThe usage of the INN stem '-antel' in the name indicates that Atelocantel is a anthelminthic. Atelocantel has a monoisotopic molecular weight of 285.13 Da.
Semotiadil
go.drugbank.com/drugs/DB20587ExperimentalThe usage of the INN stem '-dil' in the name indicates that Semotiadil is a vasodilator. Semotiadil has a monoisotopic molecular weight of 536.2 Da.
Carprazidil
go.drugbank.com/drugs/DB21012ExperimentalThe usage of the INN stem '-dil' in the name indicates that Carprazidil is a vasodilator. Carprazidil has a monoisotopic molecular weight of 291.1 Da.
GSK-2636771
go.drugbank.com/drugs/DB11795InvestigationalGSK2636771 has been used in trials studying the treatment of CANCER, LYMPHOMA, Solid Neoplasm, Recurrent Solid Neoplasm, and Advanced Malignant Neoplasm, among others.
PF-00610355
go.drugbank.com/drugs/DB11871InvestigationalPF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
Galunisertib
go.drugbank.com/drugs/DB11911InvestigationalGalunisertib has been used in trials studying the basic science and treatment of Glioma, Neoplasms, Solid Tumor, GLIOBLASTOMA, and Prostate Cancer, among others.
Lapachone
go.drugbank.com/drugs/DB11948InvestigationalLapachone has been used in trials studying the treatment of Cancer, Carcinoma, Advanced Solid Tumors, Head and Neck Neoplasms, and Carcinoma, Squamous Cell.
Triptolide
go.drugbank.com/drugs/DB12025InvestigationalTriptolide has been used in trials studying the treatment of HIV, Crohn's Disease, Intestinal Diseases, Gastrointestinal Diseases, and Digestive System Diseases, among others.
BMS-817399
go.drugbank.com/drugs/DB14941InvestigationalBMS-817399 is under investigation in clinical trial NCT01404585 (Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis).